![](/img/cover-not-exists.png)
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)
E Van Cutsem, D Cunningham, W.W Ten Bokkel Huinink, C.J.A Punt, C.G Alexopoulos, L Dirix, M Symann, G.H Blijham, P Cholet, G Fillet, C Van Groeningen, J.M Vannetzel, F Levi, G Panagos, C Unger, J WilsVolume:
35
Year:
1999
Language:
english
DOI:
10.1016/s0959-8049(98)00353-0
File:
PDF, 89 KB
english, 1999